Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...